Publisher
Springer Science and Business Media LLC
Reference95 articles.
1. Davis, K. L. & Samuels, S. C. in Pharmacological Management of Neurological and Psychiatric Disorders (eds Enna, S. J. & Coyle, J. T.) 267–316 (McGraw–Hill, New York, 1998).
2. Doody, R. S. Therapeutic standards in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 13 (Suppl. 2), S20–S26 (1999).
3. Ferris, S. H. Evaluation of memantine for the treatment of Alzheimer's disease. Expert Opin. Pharmacother. 4, 2305–2313 (2003).
4. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002). An updated summary of the amyloid hypothesis.
5. Walsh, D. M. et al. Naturally secreted oligomers of amyloid protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002).
Cited by
397 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献